Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, Icks A.

PLoS One. 2016 Jan 26;11(1):e0147329. doi: 10.1371/journal.pone.0147329. eCollection 2016. Review.

2.

Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.

Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC 3rd, Yee B, Mauer M, Nelson RG.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):254-61. doi: 10.2215/CJN.05760515. Epub 2016 Jan 20.

PMID:
26792530
3.

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.

Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS.

Kidney Int. 2016 Jan;89(1):226-34. doi: 10.1038/ki.2015.278. Epub 2016 Jan 4.

4.

Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

Nicholas SB, Iyengar SK.

Diabetes. 2013 Sep;62(9):3014-6. doi: 10.2337/db13-0748. No abstract available.

5.

Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.

Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C, Taylor A, Guiducci C, McAteer JB, McKay GJ, Isakova T, Brennan EP, Sadlier DM, Palmer C, Söderlund J, Fagerholm E, Harjutsalo V, Lithovius R, Gordin D, Hietala K, Kytö J, Parkkonen M, Rosengård-Bärlund M, Thorn L, Syreeni A, Tolonen N, Saraheimo M, Wadén J, Pitkäniemi J, Sarti C, Tuomilehto J, Tryggvason K, Österholm AM, He B, Bain S, Martin F, Godson C, Hirschhorn JN, Maxwell AP, Groop PH, Florez JC; GENIE Consortium.

Diabetes. 2012 Aug;61(8):2187-94. Epub 2012 Jun 20.

6.

Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.

Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG.

Kidney Int. 2012 Nov;82(9):1010-7. doi: 10.1038/ki.2012.234. Epub 2012 Jun 20.

7.

Insights into the genetic architecture of diabetic nephropathy.

Palmer ND, Freedman BI.

Curr Diab Rep. 2012 Aug;12(4):423-31. doi: 10.1007/s11892-012-0279-2. Review.

8.

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51. doi: 10.2215/CJN.00580111. Epub 2011 Aug 18.

9.

Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.

Chakkera HA, Hanson RL, Kobes S, Millis MP, Nelson RG, Knowler WC, Distefano JK.

Mol Genet Metab. 2011 Jun;103(2):185-90. doi: 10.1016/j.ymgme.2011.02.010. Epub 2011 Feb 19.

10.

Genetic associations in diabetic nephropathy: a meta-analysis.

Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ.

Diabetologia. 2011 Mar;54(3):544-53. doi: 10.1007/s00125-010-1996-1. Epub 2010 Dec 3. Erratum in: Diabetologia. 2014 Mar;57(3):650.

11.

Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes.

Pavkov ME, Bennett PH, Sievers ML, Krakoff J, Williams DE, Knowler WC, Nelson RG.

Kidney Int. 2005 Sep;68(3):1267-74.

12.

Diabetes outcomes in the Indian health system during the era of the Special Diabetes Program for Indians and the Government Performance and Results Act.

Wilson C, Gilliland S, Cullen T, Moore K, Roubideaux Y, Valdez L, Vanderwagen W, Acton K.

Am J Public Health. 2005 Sep;95(9):1518-22. Epub 2005 Jul 28.

13.
15.

End state renal disease among Native Americans, 1983-86.

Newman JM, Marfin AA, Eggers PW, Helgerson SD.

Am J Public Health. 1990 Mar;80(3):318-9.

16.

The changing epidemiology of diabetes mellitus among Navajo Indians.

Sugarman JR, Hickey M, Hall T, Gohdes D.

West J Med. 1990 Aug;153(2):140-5.

Items per page

Supplemental Content

Write to the Help Desk